Patients on Factor Xa Inhibitors Needing Urgent Intervention
This condition involves patients who are taking Factor Xa inhibitors, a type of blood thinner, and require urgent medical procedures that carry a high risk of bleeding.
We are studying whether TAK-330 can effectively reverse the effects of certain blood thinners in patients needing urgent surgery. This trial compares TAK-330 to the standard treatment to see which works better.
Health conditions and diseases that the clinical trial is designed to study and treat.
This condition involves patients who are taking Factor Xa inhibitors, a type of blood thinner, and require urgent medical procedures that carry a high risk of bleeding.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.